OA01.03 Immune Checkpoint Inhibitor Dose Adaptation During the COVID-19 Pandemic in Non-Small Cell Lung Cancer– a Single-Center Experience

Detalles Bibliográficos
Autores principales: Hijmering-Kappelle, L., Hiltermann, T.j.n., Bensch, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2021
Materias:
Oa01 the Impact of Covid-19 on Patients with Lung Cancer Wednesday, September 08, 2021 - 08:15-09:15
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8523140/
http://dx.doi.org/10.1016/j.jtho.2021.08.036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8523140/
http://dx.doi.org/10.1016/j.jtho.2021.08.036

Ejemplares similares